Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting.
Beuselinck, Benoit
Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Mar 2015 - 1329-39 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1557-3265
10.1158/1078-0432.CCR-14-1128 doi
Angiogenesis Inhibitors--therapeutic use
Antineoplastic Agents--therapeutic use
Carcinoma, Renal Cell--classification
Disease-Free Survival
Drug Resistance, Neoplasm
Female
Gene Expression Profiling
Humans
Indoles--therapeutic use
Kidney Neoplasms--classification
Male
Mutation--genetics
Pyrroles--therapeutic use
Sunitinib
Treatment Outcome
Vascular Endothelial Growth Factor Receptor-2--antagonists & inhibitors
Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Mar 2015 - 1329-39 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1557-3265
10.1158/1078-0432.CCR-14-1128 doi
Angiogenesis Inhibitors--therapeutic use
Antineoplastic Agents--therapeutic use
Carcinoma, Renal Cell--classification
Disease-Free Survival
Drug Resistance, Neoplasm
Female
Gene Expression Profiling
Humans
Indoles--therapeutic use
Kidney Neoplasms--classification
Male
Mutation--genetics
Pyrroles--therapeutic use
Sunitinib
Treatment Outcome
Vascular Endothelial Growth Factor Receptor-2--antagonists & inhibitors